mercaptopurine (Par Pharmaceutical Inc.)


Welcome to the PulseAid listing for the mercaptopurine drug offered from Par Pharmaceutical Inc.. This Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Par Pharmaceutical Inc.
NON-PROPRIETARY NAME: mercaptopurine
SUBSTANCE NAME: MERCAPTOPURINE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC]
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2004-02-11
END MARKETING DATE: 0000-00-00


mercaptopurine HUMAN PRESCRIPTION DRUG Details:

Item Descriptionmercaptopurine from Par Pharmaceutical Inc.
LABELER NAME: Par Pharmaceutical Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 50(mg/1)
START MARKETING DATE: 2004-02-11
END MARKETING DATE: 0000-00-00
PRODUCT ID: 49884-922_4d29e7e8-7d71-403f-aae1-ea79e1e0e0ef
PRODUCT NDC: 49884-922
APPLICATION NUMBER: ANDA040461

Other MERCAPTOPURINE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Avera McKennan HospitalMercaptopurine
Mylan Pharmaceuticals Inc.Mercaptopurine
Nova Laboratories, LtdPURIXAN
Par Pharmaceutical Inc.mercaptopurine
Physicians Total Care, Inc.mercaptopurine
Quinn Pharmaceuticals, LLCMercaptopurine
West-Ward Pharmaceuticals Corp.Mercaptopurine